Oncology – Latest Research – LinksMedicus

@oncology_linksmedicus


Oncology - Content Curation & Alerts in Medicine

Website:
https://www.linksmedicus.com/
Support our work:
https://www.buymeacoffee.com/LinksMedicus

Oncology – Latest Research – LinksMedicus

02 Apr, 10:39


📣 Explore IntelliDoctor’s New Free Voice Recognition Feature -

https://www.linksmedicus.com/news/explore-intellidoctors-new-free-voice-recognition-feature/

Oncology – Latest Research – LinksMedicus

04 Mar, 10:52


📣 Access IntelliDoctor for Free: Answers to all medical questions with our AI-based platform -

https://www.linksmedicus.com/news/access-intellidoctor-for-free-answers-to-all-medical-questions-with-our-ai-based-platform/

Oncology – Latest Research – LinksMedicus

26 Feb, 11:23


📣 Introducing IntelliDoctor: The Future of Medical Inquiry for Medical Professionals -

https://www.linksmedicus.com/news/introducing-intellidoctor-the-future-of-medical-inquiry-for-medical-professionals/

Oncology – Latest Research – LinksMedicus

18 Dec, 10:50


📣 AI-Powered GPTs for Doctors: Evidence-Based Medicine & Clinical Decision Support Prompts - IntelliDoctor

https://www.linksmedicus.com/news/ai-powered-gpts-for-doctors-evidence-based-medicine-clinical-decision-support-prompts/

Oncology – Latest Research – LinksMedicus

23 Aug, 12:53


📣 LinksMedicus.com: operations paused for the foreseeable future. - LinksMedicus

https://www.linksmedicus.com/news/linksmedicus-com-operations-paused-for-the-foreseeable-future/

Oncology – Latest Research – LinksMedicus

11 Aug, 15:25


📣 RCT | Superior PFS with avelumab vs. chemotherapy in second-line treatment for mCRC with microsatellite instability - JAMA Oncol

https://www.linksmedicus.com/news/rct-superior-pfs-avelumab-vs-chemotherapy-second-line-treatment-mcrc-microsatellite-instability/

Oncology – Latest Research – LinksMedicus

11 Aug, 15:17


📣 RCT – 2ry analysis | Aerobic exercise intervention shows potential to reduce chemotherapy-induced peripheral neuropathy - JAMA Netw Open

https://www.linksmedicus.com/news/rct-2ry-analysis-aerobic-exercise-intervention-shows-potential-reduce-chemotherapy-induced-peripheral-neuropathy/

Oncology – Latest Research – LinksMedicus

09 Aug, 15:28


📣 Phase 2 RCT | Adding stereotactic body radiotherapy to immune checkpoint inhibitors fails to improve outcomes in solid tumor patients - JAMA Oncol

https://www.linksmedicus.com/news/phase-2-rct-adding-stereotactic-body-radiotherapy-immune-checkpoint-inhibitors-fails-improve-outcomes-solid-tumor-patients/

Oncology – Latest Research – LinksMedicus

09 Aug, 15:27


📣 Cohort Study | Moderate to heavy drinking linked to increased risk of early-onset colorectal cancer - J Clin Oncol

https://www.linksmedicus.com/news/cohort-study-moderate-heavy-drinking-linked-increased-risk-early-onset-colorectal-cancer/

Oncology – Latest Research – LinksMedicus

08 Aug, 13:22


📣 Determination of “borderline resectable” pancreatic cancer – A global assessment of 30 shades of grey - HPB

https://www.linksmedicus.com/news/determination-borderline-resectable-pancreatic-cancer-global-assessment-30-shades-grey/

Oncology – Latest Research – LinksMedicus

08 Aug, 13:11


📣 Systematic Review | Pegylated liposomal doxorubicin for relapsed epithelial ovarian cancer - Cochrane Library

https://www.linksmedicus.com/news/systematic-review-pegylated-liposomal-doxorubicin-relapsed-epithelial-ovarian-cancer/

Oncology – Latest Research – LinksMedicus

08 Aug, 13:07


📣 Cohort Study | Potential negative survival impact of PPI and palbociclib co-administration in breast cancer patients - JAMA Netw Open

https://www.linksmedicus.com/news/cohort-study-potential-negative-survival-impact-ppi-palbociclib-co-administration-breast-cancer-patients/

Oncology – Latest Research – LinksMedicus

07 Aug, 14:40


📣 RCT | Upfront radiosurgery reduces tumor volume vs. a wait-and-scan approach in small- to medium-sized vestibular schwannoma - JAMA

https://www.linksmedicus.com/news/rct-upfront-radiosurgery-reduces-tumor-volume-vs-wait-scan-approach-small-medium-sized-vestibular-schwannoma/

Oncology – Latest Research – LinksMedicus

07 Aug, 14:38


📣 RCT | Zolbetuximab plus CAPOX as potential first-line treatment for CLDN18.2+, HER2- advanced gastric adenocarcinoma - Nature Med

https://www.linksmedicus.com/news/rct-zolbetuximab-plus-capox-potential-first-line-treatment-cldn18-2-her2-advanced-gastric-adenocarcinoma/

Oncology – Latest Research – LinksMedicus

04 Aug, 12:14


📣 RCT | Mammography screening with AI reduces workload by 44.3% without loss in detection efficacy - Lancet Oncol

https://www.linksmedicus.com/news/rct-mammography-screening-ai-reduces-workload-44-3-without-loss-detection-efficacy/

Oncology – Latest Research – LinksMedicus

04 Aug, 12:09


📣 Study | Removal of thymus in adults linked to increased death, cancer incidence - N Engl J Med

https://www.linksmedicus.com/news/study-removal-thymus-adults-linked-increased-death-cancer-incidence/

Oncology – Latest Research – LinksMedicus

04 Aug, 12:05


📣 NICE Updated Guideline | Diagnosis and management of lung cancer - National Institute for Health and Care Excellence

https://www.linksmedicus.com/news/nice-updated-guideline-diagnosis-management-lung-cancer/

Oncology – Latest Research – LinksMedicus

04 Aug, 12:03


📣 ASCO Guideline Update | Management of Stage III Non–Small-Cell Lung Cancer - J Clin Oncol

https://www.linksmedicus.com/news/asco-guideline-update-management-stage-iii-non-small-cell-lung-cancer/

Oncology – Latest Research – LinksMedicus

03 Aug, 13:48


📣 ACP Guidance | Asymptomatic CRC screening advised from age 50 with fecal occult blood test every 2 years or colonoscopy every 10 years - Ann Intern Med

https://www.linksmedicus.com/news/acp-guidance-asymptomatic-crc-screening-advised-age-50-fecal-occult-blood-test-every-2-years-colonoscopy-every-10-years/

Oncology – Latest Research – LinksMedicus

03 Aug, 13:36


📣 Systematic Review | Interstitial lung disease incidence at 11.7% in metastatic breast cancer patients using trastuzumab deruxtecan - ESMO Open

https://www.linksmedicus.com/news/systematic-review-interstitial-lung-disease-incidence-11-7-metastatic-breast-cancer-patients-using-trastuzumab-deruxtecan/